What's in Intermountain Health Care, Inc.'s pipeline?

Intermountain Health Care, Inc. has 3 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Intermountain Health Care, Inc.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Bayer, Biocad, Cristália Produtos Químicos Farmacêuticos Ltda., French Cardiology Society.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/intermountain-health-care-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Intermountain Health Care, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intermountain Health Care, Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Dosing of enoxaparin for VTE prophylaxis	Dosing of enoxaparin for VTE prophylaxis	marketed	Low-molecular-weight heparin (LMWH)	Factor Xa and Factor IIa (via antithrombin III enhancement)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Bayer · 1 shared drug class
Biocad · 1 shared drug class
Cristália Produtos Químicos Farmacêuticos Ltda. · 1 shared drug class
French Cardiology Society · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
HaEmek Medical Center, Israel · 1 shared drug class
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Intermountain Health Care, Inc.:

Cite this brief

Drug Landscape (2026). Intermountain Health Care, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/intermountain-health-care-inc. Accessed 2026-05-16.